February 6, 2023 by Chain Drug Review
Walmart has named Judy Werthauser as executive vice president and chief people officer, Walmart U.S.
Featured Articles, Leading Headlines, Retail News

BENTONVILLE, Ark. — Walmart has named Judy Werthauser as executive vice president and chief people officer. In this role, she will lead the people strategy within Walmart U.S., focused on career growth and associate opportunity, prioritizing well-being, driving a culture of belonging, and enhancing the company’s digital ways of working. “As the Walmart U.S. team
January 6, 2020 by Chain Drug Review
AmerisourceBergen, Capsule, Cardinal Health, Care Pharmacies, CVS Health, Discount Drug Mart, Fruth Pharmacy, Genoa Healthcare, Good Neighbor Pharmacy, Health Mart, Lewis Drug, London Drugs, McKesson Canada, Medicine Shoppe International, Pharmaca Integrative Pharmacy, PharmaChoice, Pharmasave Drugs National, Rite Aid, Senderra, Wakefern Food Corp., Walgreens Boots Alliance, Walmart U.S.
January 6, 2020

DIR fees are again top of mind for pharmacy operators beginning another year without relief from these “phantom” expenses. At the same time hope springs eternal for retailers looking to broaden affordable and accessible health care offerings when such services from more traditional providers can be out of financial reach for many people. Chains also
March 19, 2018 by Chain Drug Review
George Riedl, Marybeth Hays, Walgreens, Walmart, Walmart health and wellness, Walmart U.S.
2018, Issue 03-19-2018, Issues, News
BENTONVILLE, Ark. — George Riedl, senior vice president at Walmart and president of the Walmart Health and Wellness division, has left the company. A Walmart spokeswoman said that Riedl, a key pharmacy executive at the retail giant, departed effective March 16. The company didn’t say if a successor had been named. A former Walgreens executive,
March 7, 2018 by Chain Drug Review
George Riedl, Marybeth Hays, Walmart, Walmart health and wellness, Walmart U.S.
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

BENTONVILLE, Ark. — George Riedl, senior vice president at Walmart and president of the Walmart Health and Wellness division, is leaving the company. A Walmart spokeswoman said Wednesday that Riedl, a key pharmacy executive at the retail giant, is slated to depart on March 16. The company didn’t say if a successor had been named. A
February 20, 2018 by Chain Drug Review
Doug McMillon, Walmart, Walmart e-commerce sales, Walmart International, Walmart U.S., Walmart's fiscal 2018 sales
Business, Retail News

BENTONVLLE, Ark. — Walmart saw sales rise for its 2018 fourth quarter and fiscal year, fueled by gains across its key divisions as well as robust e-commerce growth. Walmart on Tuesday reported $136.3 billion in revenue in its fourth quarter, an increase of 4.1% from a year earlier. Walmart’s fiscal 2018 sales totaled $500.3 billion,
January 17, 2018 by Chain Drug Review
David Cheesewright, Doug McMillon, Judith McKenna, Walmart, Walmart International, Walmart U.S.
Business, Retail News

BENTONVILLE, Ark. — Walmart has promoted Judith McKenna, executive vice president and chief operating officer for Walmart U.S., to president and chief executive officer of Walmart International. The retail giant said Wednesday that McKenna will assume the new role on Feb. 1, succeeding David Cheesewright, who has led the international division — Walmart’s second-largest operating unit —
August 17, 2017 by Chain Drug Review
Doug McMillon, Sam's Club, Walmart, Walmart U.S., Walmart.com
Business, Leading Headlines, Retail News

BENTONVILLE, Ark. — Walmart reported its 12th consecutive quarter of same-store sales gains at its U.S. stores. The retail giant said Thursday that comparable-store sales for the second quarter rose 1.8% compared to a 1.6% increase in the same period of 2016. Comp sales at the Sam’s Club unit rose 1.2%, doubling the 0.6% growth
June 5, 2017 by David Pinto and Chain Drug Review
Brian Cornell, David Pinto, Jet.com, Target Corp., Walmart, Walmart International, Walmart U.S.
2017, Issue 06-05-2017, Issues, Opinion

In late May, both Walmart and Target Corp. issued their quarterly performance numbers. Each revealed some surprises, and both left those retailing authorities who still retain some faith in the business a bit more optimistic than they had been. Here’s a look at the numbers: First, Walmart. Most surprising here was the revelation that the
May 18, 2017 by Mark Baumgartner and Chain Drug Review
Doug McMillon, Sam's Club, Walmart, Walmart U.S.
Business, Retail News

BENTONVILLE, Ark. — Walmart reported strong first-quarter sales that included gains in its U.S. business, which got a lift from aggressive pricing that lured more shoppers into its stores. Store visits rose 1.5% in the quarter, a period in which many retailers saw fewer shoppers. Heavy discounting contributed to a slight decline in average basket
February 21, 2017 by Chain Drug Review
Doug McMillon, Walmart, Walmart U.S.
Business, Retail News

BENTONVILLE, Ark. — Walmart’s U.S. business accelerated in the fiscal 2017 fourth quarter, with domestic same-store sales posting their biggest increase since 2012. The retail giant said Tuesday that Walmart U.S. same-store sales rose 1.8% year over year in the fourth quarter ended Jan. 31, with the gain fueled by a 1.4% uptick in traffic.
November 17, 2016 by Geoff Walden and Chain Drug Review
Doug McMillon, Greg Foran, Walmart, Walmart U.S., Walmart’s third quarter earnings
Business, Leading Headlines, Retail News

BENTONVILLE, Ark. — Walmart’s third quarter earnings beat analysts’ expectations, but its sales fell slightly short, dampened by food deflation and unfavorable foreign exchange rates. The company earned $3.03 billion, or 98 cents a share, during the quarter, down from $1.03 per share a year ago. Analysts, on average, had projected earnings of 96 cents
August 18, 2016 by Chain Drug Review
Doug McMillon, Walmart, Walmart U.S.
Business, Leading Headlines, Retail News

BENTONVILLE, Ark. — Walmart earned $1.07 per share in the fiscal second quarter, slightly lower than its $1.08-per-share profit a year ago but above Wall Street’s consensus forecast of $1.02. The retail giant said Thursday that revenue grew 0.5% to $120.8 billion as the company notched its biggest same-store sales increase in four years. Walmart
June 6, 2016 by Chain Drug Review
Brett Biggs, Doug McMillon, Greg Foran, Greg Penner, Walmart, Walmart annual shareholders meeting, Walmart U.S.
Business, Leading Headlines, Retail News

FAYETTEVILLE, Ark. — Walmart used its 2016 shareholders meeting to drive home the message that the customer is boss and the key to the retailer’s ability to grow. “Our mission is clear,” Doug McMillon, Walmart’s president and chief executive officer, said at the June 3 Walmart annual shareholders meeting. “We save customers money so they
May 16, 2016 by Chain Drug Review
Albertsons, AmerisourceBergen, Cardinal Health, CVS, George Riedl, Mark Walchirk, McKesson, McKesson U.S. Pharmaceutical, pharmaceutical distribution, Rite Aid, Target, Walgreens Boots Alliance, Walmart, Walmart U.S.
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

SAN FRANCISCO and BENTONVILLE, Ark. — McKesson Corp. and Walmart have expanded their long-term pharmaceutical distribution pact, including a new sourcing agreement for generic drugs. McKesson and Walmart said Monday that the expanded relationship is “a natural next step.” The companies will collaborate on sourcing generics for their U.S. operations, a move that they said